Pyrrole-carboxylic acids lumilysergol esters
    1.
    发明授权
    Pyrrole-carboxylic acids lumilysergol esters 失效
    吡咯羧酸lumilysergol酯

    公开(公告)号:US3966739A

    公开(公告)日:1976-06-29

    申请号:US232605

    申请日:1972-03-07

    IPC分类号: C07D457/02

    CPC分类号: C07D457/02

    摘要: Esters of 1-methyl-lumilysergol-10-methylether having the formula: ##SPC1##Wherein R is selected from the group consisting of 2-furanoyl and the pyrrole group of the formula: ##SPC2##Wherein Y is selected from the group consisting of hydrogen, lower alkyl having from 1 to 6 carbon atoms and phenyl; R.sub.1 is selected from the group consisting of hydrogen, methyl and carbonyl; R.sub.2 is selected from the group consisting of hydrogen, methyl, halogen and carbonyl, provided that only one of R.sub.1 and R.sub.2 can be carbonyl; R.sub.3 and R.sub.4 are selected from the group consisting of hydrogen, halogen, alkyl, alkoxy having from 1 to 6 carbon atoms and carboethoxy; the pharmaceutically acceptable addition salts thereof with an organic acid and a process for the preparation thereof. The compounds possess adrenolytic, hypotensive, sedative and antiserotoninic activities.

    摘要翻译: 具有下式的1-甲基 - 亮片葡聚糖-10-甲醚的酯:

    Ercoline derivatives and therapeutic compositions having CNS affecting
activity
    2.
    发明授权
    Ercoline derivatives and therapeutic compositions having CNS affecting activity 失效
    具有CNS影响活性的Ercoline衍生物和治疗组合物

    公开(公告)号:US4382940A

    公开(公告)日:1983-05-10

    申请号:US211920

    申请日:1980-12-01

    CPC分类号: C07D457/02

    摘要: Compounds are disclosed of formula (I) ##STR1## wherein R.sub.1 represents a hydrogen atom or a methyl group; R.sub.2 represents a hydrogen atom or a methoxy group;X represents an oxygen or sulphur atom or an NH or NCH.sub.3 group;R.sub.3 represents a hydrogen atom, a trifluoromethyl or phenyl group or a hydrocarbon group having from 1 to 4 carbon atoms;R.sub.4 represents a hydrogen atom, a methyl or acetyl group or a hydrocarbon having from 1 to 4 carbon atoms, or R.sub.3 and R.sub.4 together represent a 3- or 4-membered carbon atom chain;Y represents an electron-withdrawing group such as a cyano, nitro, alkylsulphonyl or alkylsulprinyl group or a group of the formula COR.sub.5 wherein R.sub.5 represents an alkyl group having from 1 to 4 carbon atoms or a phenyl, alkoxy, amino or N-substituted amino group or R.sub.5 and R.sub.3 together represent a 2- or 3-membered carbon atom chain;R.sub.6 represents a hydrocarbon group having from 1 to 4 carbon atoms or a benzyl or phenethyl group; andR.sub.7 represents a hydrogen or halogen atom or a methyl or formyl group or a group of the formula SR.sub.8 wherein R.sub.8 represents a hydrocarbon group having from 1 to 4 carbon atoms or a phenyl group;and the pharmaceutically acceptable addition salts with organic or inorganic acids thereof. A process for producing these compounds is also disclosed.These compounds are useful antidepressant, anxiolytic and neuroleptic agents. They also display from moderate to good antiprolactinic and antihypertensive activity.

    摘要翻译: 公开了式(I)的化合物:其中R 1表示氢原子或甲基; R2表示氢原子或甲氧基; X表示氧或硫原子或NH或NCH 3基团; R3表示氢原子,三氟甲基或苯基或具有1至4个碳原子的烃基; R4表示氢原子,甲基或乙酰基或具有1至4个碳原子的烃,或R3和R4一起表示3-或4-元碳原子链; Y表示吸电子基团,例如氰基,硝基,烷基磺酰基或烷基磺基,或式COR5的基团,其中R5表示具有1至4个碳原子的烷基或苯基,烷氧基,氨基或N-取代的氨基 基团或R 5和R 3一起表示2-或3-元碳原子链; R6表示具有1至4个碳原子的烃基或苄基或苯乙基; 并且R 7表示氢或卤素原子或甲基或甲酰基或式SR 8的基团,其中R 8表示具有1至4个碳原子的烃基或苯基; 和其药学上可接受的加成盐与其有机酸或无机酸。 还公开了制备这些化合物的方法。 这些化合物是有用的抗抑郁药,抗焦虑剂和抗精神病药。 它们还显示从中度到良好的促乳素和抗高血压活性。

    Pyrimidinoaminoethyl ergoline derivatives
    3.
    发明授权
    Pyrimidinoaminoethyl ergoline derivatives 失效
    嘧啶氨基乙基麦角灵衍生物

    公开(公告)号:US3996228A

    公开(公告)日:1976-12-07

    申请号:US530617

    申请日:1974-12-09

    IPC分类号: C07D457/02

    CPC分类号: C07D457/02

    摘要: Pyrimidinoaminoethyl ergoline derivatives of the formula: ##STR1## wherein R is hydrogen or methyl; R.sub.1 and R.sub.2 are independently selected from the group consisting of hydrogen, alkyl having 1 to 3 carbon atoms, methoxy and phenyl;R.sub.3 is hydrogen, halogen, alkyl and alkoxy each having 1 to 3 carbon atoms, phenyl, nitro, amino, cyano, acylamino, carboxamido and carbalkoxy each having 1 to 3 carbon atoms, trifluoromethyl or --SO.sub.2 --Y wherein Y is hydroxyl, amino or methyl and R.sub.4 is hydrogen or methoxy are prepared by reacting an ergoline derivative of formula III and a 2-aminopyrimidine anion of formula II ##STR2##

    摘要翻译: 具有下式的嘧啶基氨基乙基麦角灵衍生物:其中R是氢或甲基; R 1和R 2独立地选自氢,具有1至3个碳原子的烷基,甲氧基和苯基; R3是氢,卤素,烷基和烷氧基,各自具有1至3个碳原子,苯基,硝基,氨基,氰基,酰氨基,甲酰胺基和碳烷氧基,各自具有1至3个碳原子,三氟甲基或-SO2-Y,其中Y是羟基, 或甲基和R 4是氢或甲氧基通过使式III的麦角灵衍生物与式II的2-氨基嘧啶阴离子反应来制备。

    8-pyridazinylcarbamoyl ergolines
    5.
    发明授权
    8-pyridazinylcarbamoyl ergolines 失效
    8-哒嗪基氨基甲酰基麦角碱

    公开(公告)号:US4675404A

    公开(公告)日:1987-06-23

    申请号:US885315

    申请日:1986-07-14

    CPC分类号: C07D457/06 C07D457/02

    摘要: Ergoline derivatives of formula: ##STR1## wherein n=0,1,2; R.sub.1 =H, CH.sub.3 ; R.sub.2 =H, CH.sub.3, halogen; R.sub.3 =H, OCH.sub.3 ; R.sub.4 =hydrocarbon group and R.sub.5 is a residue of general formula II, III, IV, V, VI, VII: ##STR2## wherein R.sub.6 =H, Cl, OCH.sub.3, NR.sub.11 R.sub.12, wherein R.sub.11 and R.sub.12 =H, lower alkyl; phenyl or are bonded together to form a heterocyclic ring, R.sub.7, R.sub.8 and R.sub.9 and R.sub.10 =H or C.sub.1 -C.sub.3 alkyl, with the proviso that if R.sub.5 is of formula II and R.sub.2 =R.sub.7 =R.sub.8 =H, then R.sub.4 is not methyl or n is not 0.Pharmaceutically acceptable acid addition salts are also provided. A method for their preparation is also provided.The compounds have anti-depressive, anti-hypertensive and antiprolactin activity.

    摘要翻译: 式:其中n = 0,1,2; R1 = H,CH3; R2 = H,CH3,卤素; R3 = H,OCH3; R4 =烃基,R5是通式Ⅱ,Ⅲ,Ⅳ,Ⅴ,Ⅵ,Ⅶ的残基:其中R6 = H,Cl,OCH3,NR11R12,其中R11和R12 = H,低级烷基; 苯基或键合在一起形成杂环,R 7,R 8和R 9和R 10 = H或C 1 -C 3烷基,条件是如果R 5为式II且R 2 = R 7 = R 8 = H,则R 4不是甲基 或n不为0.还提供药学上可接受的酸加成盐。 还提供了它们的制备方法。 该化合物具有抗抑郁,抗高血压和抗催乳素活性。

    1,6-Dimethyl-8.beta.-[2' or 3'-pyrroyloxyethyl or substituted
pyrroyloxyethyl]-10.alpha.-methoxyergolene compounds
    6.
    发明授权
    1,6-Dimethyl-8.beta.-[2' or 3'-pyrroyloxyethyl or substituted pyrroyloxyethyl]-10.alpha.-methoxyergolene compounds 失效
    1,6-二甲基-8- {62 - {8 2 {40 {0或3 {40-吡咯氧基乙基或取代的吡咯氧基乙基{9-10 {60-甲氧基己烯基化合物

    公开(公告)号:US3972883A

    公开(公告)日:1976-08-03

    申请号:US436927

    申请日:1974-01-28

    IPC分类号: A61K31/48 C07D457/02

    CPC分类号: C07D457/02

    摘要: Ergoline derivatives are disclosed having the general formula ##SPC1##Wherein R is selected from the group consisting of a lower alkyl radical having from 1 to 4 carbon atoms; an --NH-lower alkyl radical having from 1 to 4 carbon atoms; a free or substituted phenyl- or 2-furanoyl radical; the --O--CH.sub.2 --C.sub.6 H.sub.5 radical; a (3)- or (4)-pyridine radical free or substituted by a methyl radical or a chlorine or bromine atom; a pyrrole radical of formula ##SPC2##WhereinY is hydrogen, a lower alkyl radical having from 1 to 4 carbon atoms or phenyl;R.sub.1 is hydrogen or methyl;R.sub.2 is hydrogen, methyl or halogen; andR.sub.3 and R.sub.4 are the same or different and are hydrogen, halogen, a lower alkyl radical having from 1 to 4 carbon atoms, carbethoxy, or a lower alkyloxy radical having from 1 to 4 carbon atoms.Novel processes for the preparation of these compounds are also disclosed.

    摘要翻译: 公开了具有通式为WHEREIN R选自具有1至4个碳原子的低级烷基的衍生物, 具有1至4个碳原子的-NH-低级烷基; 游离或取代的苯基或2-呋喃酰基; -O-CH 2 -C 6 H 5基团; (3) - 或(4) - 吡啶基自由或被甲基或氯或溴原子取代; 式WHEREIN Y的吡咯基是氢,具有1至4个碳原子的低级烷基或苯基; R1是氢或甲基; R2是氢,甲基或卤素; 并且R 3和R 4相同或不同,为氢,卤素,具有1至4个碳原子的低级烷基,乙氧羰基或具有1至4个碳原子的低级烷氧基。

    Ergot derivatives
    7.
    发明授权
    Ergot derivatives 失效
    Ergot衍生物

    公开(公告)号:US4252941A

    公开(公告)日:1981-02-24

    申请号:US72289

    申请日:1979-09-04

    CPC分类号: C07D457/02

    摘要: Compounds and process for making same are disclosed, the compounds having the formula (I): ##STR1## wherein R.sub.1 represents a methyl, phenyl, piperidino, 1-pyrrolidinyl, morpholino or 4-methyl-1-piperazinyl group, an alkyl or alkoxy group having from 1 to 4 carbon atoms, an amino group, a substituted amino group of the formula NHR' (wherein R' represents an alkyl group having from 1 to 4 carbon atoms, a cycloalkyl group, a benzyl group, or a phenyl group) or a substituted amino group of the formula NR" R"' (wherein R" and R"' both represent alkyl groups having from 1 to 4 carbon atoms);R.sub.2 represents a hydrogen atom, an alkyl group having from 1 to 4 carbon atoms, or a phenyl group;R.sub.3 represents a fluorine atom, a cyano, difluoromethyl, difluorobromomethyl, trifluoromethyl, methylthio, methylsulphonyl, or sulphonamido group, an alkoxy group having from 1 to 4 carbon atoms, an acyl group having from 2 to 4 carbon atoms, or a benzoyl group;R.sub.4 represents a hydrocarbon group having from 1 to 4 carbon atoms;R.sub.5 represents a hydrogen atom or a methoxy group;R.sub.6 represents a hydrogen or halogen atom or a methyl group; andR.sub.7 represents a hydrogen atom or a methyl group.The 2-cyano derivatives are especially preferred.

    摘要翻译: 公开了化合物及其制备方法,具有式(I)的化合物:其中R 1表示甲基,苯基,哌啶子基,1-吡咯烷基,吗啉代或4-甲基-1-哌嗪基, 具有1至4个碳原子的烷基或烷氧基,氨基,式NHR'的取代氨基(其中R'表示具有1至4个碳原子的烷基,环烷基,苄基或 苯基)或式NR“R”'的取代氨基(其中R“和R”“均表示具有1至4个碳原子的烷基); R2表示氢原子,具有1至4个碳原子的烷基或苯基; R 3表示氟原子,氰基,二氟甲基,二氟溴甲基,三氟甲基,甲硫基,甲磺酰基或磺酰胺基,具有1至4个碳原子的烷氧基,具有2至4个碳原子的酰基或苯甲酰基; R4表示具有1至4个碳原子的烃基; R5表示氢原子或甲氧基; R6表示氢或卤素原子或甲基; 并且R 7表示氢原子或甲基。 2-氰基衍生物是特别优选的。

    Ergot derivatives
    8.
    发明授权
    Ergot derivatives 失效
    Ergot衍生物

    公开(公告)号:US4321381A

    公开(公告)日:1982-03-23

    申请号:US188620

    申请日:1980-09-19

    CPC分类号: C07D457/02

    摘要: Compounds and process for making same are disclosed, the compounds having the formula (I): ##STR1## wherein R.sub.1 represents methyl, phenyl, piperidino, 1-pyrrolidinyl, morpholino or 4-methyl-1-piperazinyl, alkyl or alkoxy having from 1 to 4 carbon atoms, amino, substituted amino of the formula NHR' (wherein R' is alkyl having from 1 to 4 carbon atoms, cycloalkyl, a benzyl, or phenyl) or substituted amino of the formula NR" R"' (wherein R" and R"' both represent alkyl having from 1 to 4 carbon atoms);R.sub.2 represents a hydrogen atom, alkyl having from 1 to 4 carbon atoms, or phenyl;R.sub.3 represents a fluorine atom, cyano, difluoromethyl, difluorobromomethyl, trifluoromethyl, methylthio, methylsulphonyl, sulphonamido, an alkoxy having from 1 to 4 carbon atoms, an alkanoyl having from 2 to 5 carbon atoms, or benzoyl;R.sub.4 represents a hydrocarbon having from 1 to 4 carbon atoms;R.sub.5 represents a hydrogen atom or methoxy;R.sub.6 represents a hydrogen or halogen atom or methyl; andR.sub.7 represents a hydrogen atom or methyl. The 2-cyano derivatives are especially preferred.The compounds are useful as antihypertensive agents.